This segment focuses on the development, manufacturing, and marketing of human clinical diagnostic solutions. Hemagen offers a comprehensive line of VIRGO immunoassays for diagnosing autoimmune and infectious diseases, as well as acute phase proteins. The company utilizes ELISA technology and other immunoassay methods. Research and development efforts are focused on expanding the test menu and improving assay performance. The segment's products are used in various laboratories, hospitals, and blood banks. The company's market position is strengthened by its FDA-cleared tests and direct sales channels. Future opportunities include expanding into new disease areas and developing companion diagnostics. Regulatory compliance is a key aspect, with products requiring FDA clearance. The company has partnerships with distributors to reach a wider customer base. The impact is improved patient outcomes through accurate and timely diagnosis.

This segment provides diagnostic solutions for veterinary applications. Hemagen offers equipment, reagents, supplies, and accessories for chemistry, hematology, and electrolyte testing in veterinary laboratories. The company's R&D activities focus on developing and improving diagnostic tools for animal health. The segment utilizes various technologies, including ELISA and other immunoassay methods. The therapeutic areas covered include a wide range of animal diseases. The company's market position is enhanced by its focus on veterinary diagnostics and direct sales. Future opportunities include expanding the product line and entering new geographic markets. The company's products are sold through distributors. The impact is improved animal health through accurate and timely diagnosis.